sport galleries
cambridge's bluebird bio licenses delivery tech to novartis, gsk http://lm360.us/Yahne-son-of-Soboleski-from-San-Jos-De-Guanipa?Chafferda=219
it's not clear how well they'll stack up against current migraine therapies, because head-to-head studies haven't been done. .